ATE188707T1 - Verfahren zur herstellung von alanylglutamin - Google Patents

Verfahren zur herstellung von alanylglutamin

Info

Publication number
ATE188707T1
ATE188707T1 AT93117578T AT93117578T ATE188707T1 AT E188707 T1 ATE188707 T1 AT E188707T1 AT 93117578 T AT93117578 T AT 93117578T AT 93117578 T AT93117578 T AT 93117578T AT E188707 T1 ATE188707 T1 AT E188707T1
Authority
AT
Austria
Prior art keywords
producing
alanyl glutamine
substituted
alanylglutamine
producing alanyl
Prior art date
Application number
AT93117578T
Other languages
English (en)
Inventor
Kunimi Inoue
Yoshiyuki Yamada
Kazumi Amatsu
Yukiteru Mimura
Yasunori Nakaguchi
Hiroyuki Shinmura
Yasuyuki Ono
Yutaka Osawa
Shoichi Mizutaki
Masaji Kasai
Shinji Tomioka
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of ATE188707T1 publication Critical patent/ATE188707T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/64Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66Methanesulfonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/72Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/73Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT93117578T 1992-10-29 1993-10-29 Verfahren zur herstellung von alanylglutamin ATE188707T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29113992 1992-10-29

Publications (1)

Publication Number Publication Date
ATE188707T1 true ATE188707T1 (de) 2000-01-15

Family

ID=17764957

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93117578T ATE188707T1 (de) 1992-10-29 1993-10-29 Verfahren zur herstellung von alanylglutamin

Country Status (6)

Country Link
US (2) US5380934A (de)
EP (1) EP0595345B1 (de)
AT (1) ATE188707T1 (de)
CA (1) CA2109482C (de)
DE (1) DE69327567T2 (de)
ES (1) ES2141748T3 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3440129B2 (ja) * 1994-04-18 2003-08-25 協和醗酵工業株式会社 グルタミン誘導体の製造法
AU3927400A (en) * 1999-04-01 2000-10-23 University Of Virginia A process for the production of glutamine derivatives and glutamine containing molecules
AU4251300A (en) 1999-05-07 2000-11-21 University Of Virginia Patent Foundation Biological production of stable glutamine, poly-glutamine derivatives in transgenic organisms and their use for therapeutic purposes
SE0201713D0 (sv) 2001-11-23 2002-06-06 Gramineer Internat Ab New methods and use III
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (de) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
JP4931801B2 (ja) * 2005-03-29 2012-05-16 協和発酵バイオ株式会社 ジペプチドの結晶およびその製造法
CN101062938B (zh) * 2006-04-25 2010-09-01 福建三爱药业有限公司 N(2)-l-丙氨酰-l-谷氨酰胺的制备方法
IN2012DN03157A (de) 2009-10-12 2015-09-18 Boehringer Ingelheim Vetmed
AU2010347598B2 (en) 2010-03-03 2014-11-27 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
CN102093250B (zh) * 2010-12-02 2013-03-20 海南本创医药科技有限公司 一种丙氨酰谷氨酰胺化合物的精制方法
CN102260189B (zh) * 2011-05-31 2014-05-21 四川科伦药物研究有限公司 一种制备n(2)-l-丙氨酰-l-谷氨酰胺的关键中间体n(2)-d-2-氯丙酰-l-谷氨酰胺的方法
CN103012191B (zh) * 2011-09-26 2015-04-22 重庆莱美药业股份有限公司 一种制备d-2-取代丙酰-l-谷氨酰胺的方法
CN103012550B (zh) * 2011-09-26 2014-12-10 重庆莱美药业股份有限公司 一种制备n(2)-l-丙氨酰-l-谷氨酰胺的方法
CN102491918B (zh) * 2011-11-28 2013-07-10 海南灵康制药有限公司 一种丙氨酰谷氨酰胺化合物及其制法
CN102731613B (zh) * 2012-07-18 2013-12-11 济南诚汇双达化工有限公司 一种l-丙氨酰-l-谷氨酰胺的制备方法
CN103910780A (zh) * 2014-04-09 2014-07-09 上海皓骏医药科技有限公司 L-丙氨酸-l-谷胺酰胺化合物的制备方法
CN110099919B (zh) 2016-12-20 2023-11-28 协和发酵生化株式会社 L-丙氨酰-l-谷氨酰胺的晶体及其制造方法
CN106701869A (zh) * 2016-12-30 2017-05-24 山东辰龙药业有限公司 N(2)‑l‑丙氨酰‑l‑谷氨酰胺的制备方法
CN110845351A (zh) * 2019-10-08 2020-02-28 安徽生源化工有限公司 一种氯丙酰谷氨酰胺的生产工艺
CN112574277A (zh) * 2020-12-31 2021-03-30 南京肽谷生物科技有限公司 一种丙氨酰谷氨酰胺的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3206784C2 (de) * 1982-02-25 1985-05-09 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen Glutaminhaltige Zubereitungen für orale oder intravenöse Applikation
JPH0699473B2 (ja) * 1986-08-21 1994-12-07 味の素株式会社 グリシル―グルタミンの製造方法
JPH0832717B2 (ja) * 1987-10-07 1996-03-29 味の素株式会社 グルタミン誘導体の製造方法

Also Published As

Publication number Publication date
DE69327567T2 (de) 2000-09-14
CA2109482A1 (en) 1994-04-30
EP0595345A1 (de) 1994-05-04
ES2141748T3 (es) 2000-04-01
CA2109482C (en) 2005-01-04
EP0595345B1 (de) 2000-01-12
US5380934A (en) 1995-01-10
US5550283A (en) 1996-08-27
DE69327567D1 (de) 2000-02-17

Similar Documents

Publication Publication Date Title
ATE188707T1 (de) Verfahren zur herstellung von alanylglutamin
ATE145891T1 (de) Verfahren zur herstellung von alkoxyiminoacetamid-derivaten und ein zwischenproduckt dafür
ATE176784T1 (de) Verfahren zur herstellung von n- biphenylmethylthiadiazolin derivaten oder deren salzen sowie dafür benötigte zwischen verbindungen
DK163303C (da) Fremgangsmaade til fremstilling af cimetidin polymorf b.
DE69432176T2 (de) Verfahren zur herstellung von hiv protease inhibitoren
DE3889772T2 (de) Verfahren zur Herstellung von 3,3-Diarylacrylsäureamiden.
ATE172734T1 (de) Verfahren zur herstellung von ceftriaxon
ATE259794T1 (de) Verfahren zur herstellung von 3-hydroxy- tetrahydrofuran
ATE46322T1 (de) Verfahren zur herstellung von bestatin-derivaten und deren zwischenprodukte.
DE69809888D1 (de) Verfahren zur Herstellung von alpha-Aminoketonen
ATE190306T1 (de) Verfahren zur herstellung von 2-chlor-5- aminomethylpyridin
DK0492350T3 (da) Fremgangsmåde til fremstilling af (S)-vinyl- og (S)-allenyl-GABA
ATE18208T1 (de) N-(4-hydroxyphenyl)essigsaeureamid-estern aus 5benzoyl-1-methylpyrrol-2-essigsaeure.
ATE240937T1 (de) Gamma-oxohomophenylalanin derivate und ein verfahren zur herstellung von homophenylalanin derivaten durch reduktion derselben
DE60028998T8 (de) Verfahren zur herstellung einer benzylamin-verbindung
DE69716370T2 (de) Verfahren zur herstellung von beta-lactam verbindungen
ATE92481T1 (de) Verfahren zur herstellung von n,n'-bis-(2hydroxyethyl)-piperazin.
ATE205497T1 (de) Verfahren zur herstellung von 3-norcephem- verbindungen
DK161599C (da) Fremgangsmaade til fremstilling af lysergsyreestere

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner